Cormorant Asset Management, Other: MoonLake Immunotherapeutics MLTX Sell · Filed 25/10/01

Trade details

Type: Insider sale
Amount: $1,952,664
Shares · price: 232,460 sh · $8.40 a share
Held after: 8,190,943 sh
Stock: MoonLake Immunotherapeutics MLTX
Person: Cormorant Asset ManagementOther
Trade date: 25/09/29
Filed: 25/10/01
Days to filing: 2 days

Sold 2.8% of holdings

Share of holding sold: 2.8%

MoonLake Immunotherapeutics trades, last 26 weeks

What else happened in MoonLake Immunotherapeutics around then

Filed or reported within 30 days of the trade day · 25/08/30~25/10/29

Cormorant Asset Management's recent trades

Cormorant Asset ManagementOther
SellBright Minds Biosciences
Sell
Bright Minds Biosciences
DRUG
$9.8M
109,331 sh
$9.8M
Filed 04/30
Traded 04/28
Cormorant Asset Management10% Owner
SellCorbus Pharmaceuticals Holdings
Sell
Corbus Pharmaceuticals Holdings
CRBP
$344.1K
30,029 sh
$344.1K
Filed 25/12/15
Traded 25/12/11
Cormorant Asset ManagementOther
SellEyePoint
Sell
EyePoint
EYPT
$942K
60,000 sh
$942K
Filed 25/12/08
Traded 25/12/04
Cormorant Asset ManagementOther
SellMoonLake Immunotherapeutics
Sell
MoonLake Immunotherapeutics
MLTX
$25.7M
3,390,943 sh
$25.7M
Filed 25/10/01
Traded 25/09/29
Cormorant Asset ManagementOther
SellMoonLake Immunotherapeutics
Sell
MoonLake Immunotherapeutics
MLTX
$18.5M
2,800,000 sh
$18.5M
Filed 25/10/01
Traded 25/09/29